MIAMI, FL--(Marketwired - February 28, 2017) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces strong start to 2017.
PharmCo continues to deliver year over year growth, filling over 17,500 prescriptions and garnering revenues of $1.6 million for the month, which is a 12% and 22% increase over January 2016 respectively. The Company is in the middle of what is commonly called "deductible season" where costly health care decisions are deferred until after deductibles are met for the year. During this period, typically the first quarter of the year, new prescriptions therapies are lower when compared to the rest of the year.
"This is a really exciting start to year," stated S. Parikh Mars, CEO. "We are completing the audit of the 2016 Annual Report, focused on building new relationships with doctors, clinics, and long term care facilities, and pushing forward on our aggressive growth agenda. We are emboldened by the new opportunities we have in front of us, like our Century Village Resource Center and Smart Medical Alliance and are looking forward to strong results from both of these ventures this year."
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.